Buyer Class Fights Allergan Over Causation In Antitrust Row

A class of end purchasers accusing Allergan PLC and its subsidiary Warner Chilcott Ltd. of stifling competition for their ulcerative colitis drugs urged a Massachusetts federal court Monday not to certify...

Already a subscriber? Click here to view full article